Mondaq All Regions: Food, Drugs, Healthcare, Life Sciences > Life Sciences, Biotechnology & Nanotechnology
Sadany & Khalifa Law Firm
Egypt's pharmaceutical market is one of the most important attractive countries in the Middle East and North Africa.
Steptoe & Johnson LLP
In our 281st episode of The Cyberlaw Podcast, Stewart Baker is joined by David Kris (@DavidKris) and Nick Weaver (@ncweaver) to discuss
Fross Zelnick Lehrman & Zissu, PC
Viridis Pharmaceutical Ltd.'s (Viridis) use of BOSWELAN in connection with clinical trials for a drug to treat multiple sclerosis was held to be insufficient evidence of genuine use to defeat a non-use cancellation action ...
Singh & Associates
This segment discusses the recent drug approvals from the US FDA in various severe diseases. The write-ups describe the role of a new drug in the treatment of serious conditions such as myeloma
Singh & Associates
On July 19, 2019, Delhi High Court granted permanent injunction against Lee Pharmaceuticals, restraining it from infringing the copyright of Mankind Pharma Ltd.
Global Advertising Lawyers Alliance (GALA)
In Singapore, it is illegal to sell and supply products which contain undeclared potent medicinal ingredients.
STA Law Firm
Imagine that you are an entrepreneur in the pharmaceutical industry having recently made a scientific breakthrough in a critical field.
Ropes & Gray LLP
On September 27, 2019, the U.S. Food and Drug Administration ("FDA") issued a revised draft guidance entitled "Clinical Decision Support Software"
Reed Smith
This post is a follow-up of sorts to our "Stupid Expert Tricks" post. That post dealt with dodgy games that our opponents' experts play.
McDermott Will & Emery
The FDA recently released six guidance documents as part of the agency's continued focus on updating the regulatory stance on software as a medical device and other digital health products
Butler Snow LLP
If you have ever read The Jungle Book, a collection of stories by Rudyard Kipling, Rikki-Tikki-Tavi should sound familiar.
Foley Hoag LLP
On September 18, 2019, the Department of Justice announced a $21.36 million settlement to resolve a False Claims Act ("FCA")
Duane Morris LLP
With the advancements in technology and the advent of artificial intelligence, the medical device industry is flourishing.
Duane Morris LLP
The FCA creates liability for persons or entities found to have knowingly submitted false claims to the government or having caused others to do so.
Wilson Sonsini Goodrich & Rosati
The U.S. Food and Drug Administration (FDA) continues advancing regulatory policies tailored to the digital health community. On September 26, 2019
Hogan Lovells
On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released a series of guidance documents addressing the agency's ...
Hogan Lovells
On 27 September 2019 the U.S. Food and Drug Administration (FDA or the agency) released the draft guidance entitled "Clinical Decision Support Software" (CDS guidance), ...
Duane Morris LLP
Genetic testing and telemedicine targeting senior citizens and individuals with disabilities have been the subject of growing government scrutiny.
Foley Hoag LLP
On September 18, 2019, the Department of Justice announced a $21.36 million settlement to resolve a False Claims Act ("FCA")
Reed Smith
Today's guest post is by Reed Smith‘s Jenn Eppensteiner. In it she discusses a recurring theme on the Blog – claimed product "defects" arising from nothing more than the failure of an implanted ...
Latest Video
Most Popular Recent Articles
Cyril Amarchand Mangaldas
Gujarat has been the flag bearer of India's pharmaceutical industry since the establishment of the country's second oldest drug company
Reed Smith
Donald Rumsfeld once justified attacking Iraq without firm evidence that his target possessed the ultimately apocryphal
Oblon, McClelland, Maier & Neustadt, L.L.P
Design patents are very different from utility patents in that design patents only protect the ornamental features of an invention. In contrast to utility patents, the design is defined
Sheppard Mullin Richter & Hampton
On September 26, 2019, the US Food and Drug Administration (FDA) published six guidance documents clarifying its scope of authority and enforcement...
Shook, Hardy & Bacon L.L.P.
Plaintiffs' attorneys are spending billions of dollars saturating the airwaves with advertisements that target prescription drugs and medical devices for lawsuits.
Arnold & Porter
Viridis's use of the BOSWELAN mark during the clinical trial was purely internal in nature.
Marshall, Gerstein & Borun LLP
What is synthetic biology? At a fundamental level, synthetic biology is an interdisciplinary area applying engineering principles to biology ...
Reed Smith
Today's guest post is by Reed Smith‘s Jenn Eppensteiner. In it she discusses a recurring theme on the Blog – claimed product "defects" arising from nothing more than the failure of an implanted ...
AZB & Partners
Any business interested in establishing a business in India is required to first ascertain whether the business is to operate as a foreign entity having a presence in India
Khurana and Khurana
A decade ago, the whole country was sent flying into a state of bewilderment by the news headlines flashing on the TV screens that morning.
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter